NOX2-ROS-NLRP3

Janeen Laabei1, Gloria Vegliante1, Nathan Ryzewski Strogulski1

  • 1Neurotrauma and Neuroimmunology Research, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.

PubMed
概括

使用GSK2795039的NOX2的药理抑制可以减少神经炎症,并改善创伤性脑损伤 (TBI) 后的结果. 这种NOX2抑制剂向ROS-NLRP3炎症酶轴和髓状T细胞交叉,提供了一个有前途的治疗策略.